Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells

This 2003 *Bulletin of Experimental Biology and Medicine* paper by Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology is the foundational primary mechanism paper for Epitalon and the source of the modern claim that a short tetrapeptide can induce telomerase activity in human somatic cells. The investigators added Epithalon (the AEDG tetrapeptide) to cultures of human fetal fibroblasts — cells that are normally telomerase-negative and senesce within a defined replicative lifespan — and measured three sequential outcomes: induction of expression of the telomerase catalytic subunit (hTERT), measurable enzymatic activity of telomerase, and elongation of telomere length over the experimental timeframe. All three were observed in Epithalon-treated cultures and absent in controls. The authors interpreted the findings as evidence that Epithalon reactivates normally silenced telomerase genes in somatic cells, opening a candidate route to extending replicative lifespan and supporting the molecule's broader claims for organismal longevity. The paper is cited in essentially every subsequent review and primary work on Epitalon. ### Methods (verified) - **Cell lines.** Human embryonic (fetal) lung fibroblasts — a normal, telomerase-negative diploid line — and HeLa cells (telomerase-positive, used as a positive control). - **Treatment.** Epithalon peptide (Ala-Glu-Asp-Gly, AEDG) added to the culture medium. The published note is a 3-page short report (Bull Exp Biol Med 135(6):590–592 in the Springer English issue; Russian original paginated 692–695); exact peptide concentration, treatment duration, and replicate counts are not reported in publicly accessible portions of the paper. - **Readouts.** hTERT mRNA expression by reverse-transcription PCR; telomerase enzymatic activity by the TRAP assay (telomeric repeat amplification protocol); telomere length / chromosomal localization by fluorescence in situ hybridization (FISH) with flow-cytometry quantification; proliferative capacity tracked across serial passages versus untreated control cultures. ### Results (verified high-confidence + secondary-citation numerics) - In telomerase-negative human fetal lung fibroblasts, Epitalon **induced hTERT mRNA expression** (RT-PCR) and **reactivated telomerase enzymatic activity** (TRAP) in cells that had no detectable activity at baseline. - **Telomeres elongated** in treated fibroblasts. Secondary review literature citing this paper reports approximately **2.4-fold telomere lengthening** versus controls. (Confidence: medium — this exact figure is widely attributed to this 2003 paper but verifiable only through secondary citations, not the paper's primary text, which is paywalled past abstract.) - **Proliferative lifespan extended past the Hayflick limit:** untreated fibroblasts senesced around passage 34, while Epitalon-treated cultures continued dividing beyond passage 44 (>10 additional population doublings). (Confidence: medium — same secondary-citation provenance as the 2.4× figure.) - HeLa cells (already telomerase-positive) served as comparator; the action on telomerase has been characterized by later citing work as occurring during the G1 phase of the cell cycle. The Springer English-translation abstract concludes: *"Addition of Epithalon peptide in telomerase-negative human fetal fibroblast culture induced expression of the catalytical subunit, enzymatic activity of telomerase, and telomere elongation, which can be due to reactivation of telomerase gene in somatic cells and indicates the possibility of prolonging life span of a cell population and of the whole organism."*

This is a cell-culture study in fetal fibroblasts, not a human clinical trial — the translation from in-vitro telomere and telomerase findings to in-vivo human lifespan or aging biomarkers is a long inferential chain, not a demonstrated equivalence. The paper is published in a Russian journal (the Bulletin of Experimental Biology and Medicine, which is translated and indexed in PubMed but originates from the same national research ecosystem as the broader Khavinson program). The findings have been extended in subsequent Western-journal work (a 2025 *Biogerontology* paper replicated the cell-line telomere-lengthening finding via telomerase upregulation or alternative-lengthening-of-telomeres activity), but the independent Western RCT translation of any clinical claim has not happened. Telomerase reactivation in somatic cells is also mechanistically tumor-permissive; the paper does not address the cancer-biology implications, which are non-trivial for anyone considering chronic exogenous administration. Read the result as a real cell-culture mechanistic finding, not as evidence that the equivalent process operates in vivo in humans on Epitalon administration. The paper itself is a 3-page short report; granular numerics (peptide concentration, kb-level telomere measurements, TRAP unit values, replicate counts, statistical tests) are reported in figures behind the Springer paywall. The 2.4-fold telomere elongation figure and the passage-34 → passage-44+ lifespan extension are widely repeated in secondary review literature citing this paper, but the editorial entry here flags them as *"as reported by reviewers citing this paper"* rather than primary-source-verified, until institutional access to the Springer PDF or an archived institutional copy resolves the gap. ### Translator notes (2026-05-05) AI-translation pass attempted via WebFetch on the Khavinson institute archive — the institutional host returned HTTP 503 across multiple attempts; Springer is paywalled past abstract; ResearchGate requires login. Verbatim Springer English-translation abstract is reproduced above; structured methods + results bullets are paraphrased from the abstract plus secondary review citations of the 2003 paper. Confidence breakdown: **high** for cell types, assays, qualitative conclusion, abstract verbatim; **medium** for the 2.4× telomere figure and passage-34 → 44+ result; **low / unknown** for exact peptide concentration, telomere length in kb, TRAP unit values, statistical tests. This entry will update when the institute archive comes back online or when a primary-source figure-set is accessed.